Dr. Barbara Hempstead, dean of the Weill Cornell Graduate School of Medical Sciences, has been awarded Weill Cornell Medicine’s Joan and Sanford I. Weill Exemplary Achievement Award.
Weill Cornell Medicine scientists have built the first global database of clinical trials testing a rapidly expanding approach to cancer treatment that involves genetically modifying immune cells to recognize specific targets on a patient’s cancer cells and attack them.
A new technology developed by Weill Cornell Medicine and Max Planck Institute for Medical Research scientists allows the controlled, on-and-off “switching” of neural receptors with unprecedented efficiency and precision.
A protein that breast, lung and other cancers use to promote their spread—or metastasis—to the brain, has been identified by a team led by Weill Cornell Medicine and New York-Presbyterian investigators. The protein, CEMIP, will now be a focus of efforts to predict, prevent and treat brain metastases, which are a frequent cause of cancer deaths.
More than 80 Weill Cornell Medicine students, faculty and senior leadership gathered Oct. 7 at Weill Cornell Medicine for a ribbon-cutting ceremony for the Feil Family Student Center, which occupies renovated first and second floors in the main campus buildings on York Avenue. The state-of-the-art center was made possible by a $12.5 million gift from the Feil Family.
Weill Cornell Medicine hosted the first-ever National Conference on Medical Student Mental Health and Well-Being Sept. 18-19, in partnership with the Association of American Medical Colleges, Associated Medical Schools of New York and the American Foundation for Suicide Prevention,
Medical conditions and health habits that affect blood flow in the brain—or cerebrovascular risk factors—are associated with a subsequent diagnosis of Parkinson’s disease, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian investigators.
Chemical modifications that appear on some RNA transcripts may have evolved in part to help cells repair themselves after damage, and may also be a key to understanding important human diseases, according to new research from scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.
The Weill Cornell Graduate School of Medical Sciences has been awarded a competitive grant from the National Institutes of Health to launch a program dedicated to increasing the number and enhancing the success of doctoral students from underrepresented backgrounds.
The Executive M.B.A./M.S. in Healthcare Leadership program, offered jointly by the Weill Cornell Graduate School of Medical Sciences and Cornell’s Samuel Curtis Johnson Graduate School of Management in May celebrated a milestone: graduating its first class of 39 students.
More than 370 students celebrated a milestone on May 30: graduating from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences and Weill Cornell Medicine-Qatar.
On the eve of their commencement, students from Weill Cornell Medical College and Weill Cornell Graduate School of Medical Sciences were recognized for their outstanding achievements.
Dr. Katharine Hsu, M.D. ’94, Ph.D. ’93, professor of medicine and attending physician at Memorial Sloan Kettering Cancer Center, has been awarded the Weill Cornell Graduate School Alumni Award of Distinction.
A new technique developed by Weill Cornell Medicine investigators that creates an unusually stable form of RNA may illuminate many cellular processes and enable new kinds of gene therapies.
Comic actor Seth Rogen and his wife are open about how Alzheimer’s disease has affected their family: her mother suffers from its early-onset form, and by age 60 she could no longer speak.
Weill Cornell Medicine has experienced dynamic growth in its research enterprise over the past five years, an achievement that underscores the institution’s mission to provide patients with the most advanced treatments and therapies.
